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1. Introduction 
The existence of additional serum proteins in the 
blood of pregnant women is an established fact (for 
example [l-8] ). One of these, a high molecular weight 
o-globulin [4], is the most commonly found and has 
been obtained in a pure form [7,9]. It is a glycoprotein 
containing 10% carbohydrate and having an iso-electric 
point of 4.6 [9] . This pregnancy-associated o-macro- 
globulin (PAM) has been quantitated in the blood of 
subjects with a variety of conditions and its level 
appears to be particularly dependent on the presence 
of oestrogens [6,8,10,11]. However the protein has 
been shown not to be involved in steroid transport 
[ 12- 141. A recent investigation has indicated that 
peripheral blood leucoctyes are responsible for the 
synthesis of PAM [ 151 but its biological role is as yet 
uncertain. 
This study was carried out to produce a sensitive 
method for assaying PAM that could be employed 
the necessity for expensive equipment. The use of 
radioactive labels as markers for proteins is well known 
but they are often difficult to use because of the short 
half-life of the isotopes employed and because of the 
possibility of radiation damage to the molecule, which 
could effect its immunochemical reactivity. For these 
reasons an enzyme was used as marker [ 16- 181 for 
the antibody to PAM in the ‘sandwich’ immunoassay 
developed. 
2. Materials and methods 
2.1. Reagents 
Horse radish peroxidase (HRP), grade 1, RZ = 3 .O, 
was obtained from Miles-Seravac; glutaraldehyde (25% 
190 
aqueous solution) from B.D.H.; bovine serum albumin, 
Fraction V, from Sigma; 5aminosalicylic acid from 
Emmanuel, Wembley, England, polystyrene test tubes 
(3 ml) from Sarstedt: Analar grade reagents were used 
wherever possible. 
Pure PAM [9] and Freunds’ complete adjuvant were 
used for immunising rabbits and the resultant antiserum 
was prepared by 50% ammonium sulphate precipitation 
and DEAE-cellulose fractionation [ 191 of the serum 
obtained. The anti-PAM was absorbed four times with 
4B Sepharose coupled to male serum proteins by the 
cyanogen bromide method [20]. The specificity of 
the antiserum was checked by two dimensional 
immunoelectrophoresis [2 1 ] . 
Except, where indicated, 0.04 M phosphate buffer, 
pH 7.4, containing 0.5 M NaCl was used in the follow- 
ing procedures. 
2.2. Preparation of antibody-HRP conjugates 
1 mg antibodies to PAM and 5 mg HRP were 
dissolved in 2 ml 0.04 M phosphate buffer, pH 7.4, 
containing 2.5% glutaraldehyde and shaken at room 
temperature for 3 hr [ 181. No precipitation occured 
during this procedure. The solution was then subjected 
to gel filtration on a column (1.6 X 40 cm) of Sephadex 
G-l 50 equilibrated with the buffer described above, 
at 4°C. The flow rate was 6 ml/hr and the effluent was 
continuously monitored for protein at 280 nm. Frac- 
tions of 2.4 ml were collected and the tubes containing 
the conjugate were pooled (fig. 1) and stored at -20°C. 
2.3. Determination of HRPactivity 
A substrate solution was prepared by dissolving 
40 mg 5-aminosalicylic in 100 ml of 0.02 M phosphate 
buffer, pH 6.0, containing 5 ~130% Hz O2 [ 171. In the 
North-Holland Publishing Company - Amsterdam 
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Fig. 1. Gel chromatography of antibody-HRP conjugate on a 
column of Sephadex G150. The fraction indicated by the 
black bar was collected. 
assay 1 ml of freshly prepared substrate was added to 
the empty polystyrene tubes and the absorbance at 
450 nm read after 1 hr at room temperature. 
2.4. Preparation of antibody coated tubes 
The anti-PAM was diluted with buffer and 0.6 ml 
of the solution incubated in each polystyrene tube [22] 
for 15 min at room temperature. The tubes were then 
washed three times with buffer, filled with 1% bovine 
serum albumin and re-incubated. The tubes could then 
be stored at 4°C until used. 
2.5. Enzyme-immunoassay procedure 
A 0.5 ml sample (standards O-200 &!/ml PAM or 
pregnancy serum 1: lo- 1: 100 diluted) was placed in 
each antibody-coated tube and incubated at 37’C for 
45 min. The tubes were then washed three times with 
buffer containing 0.1% Triton X-100 and 0.6 ml 
aliquots of diluted antibody-HRP conjugate, containing 
approximately 20 mIU HRP activity, were added. 
After a further incubation of 2 hr at room temperature 
the test tubes were washed three times with buffer and 
the HRP activity determined as above. 
3. Results and discussion 
The conjugate was purified by gel chromatography 
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Fig. 2. Standard curves for PAM assay with various antibody 
dilutions. A (l:lOOO), B (1:3000), C cl:10 000). 
and a typical elution profile is shown in fig. 1. The 
unreacted HRP (second peak) was adequately separated 
from that bound to antibody and the fractions indicated 
were pooled and normally used at 1: 30- 1: 40 dilution. 
In fig. 2 three standard curves for the assay are indicaled. 
The lower limit of sensitivity is approximately 0.2 E.cg/ 
ml while the upper limit, with an antibody dilution of 
1: 1000, is 100 pug/ml. Thus a wide range of concentra- 
tions can be covered with a single standard curve is 
necessary. The method was compared with the Laurel1 
‘rocket technique’ of quantitative immunoelectrophoresis 
[23] by determining the PAM concentration in the 
serum of 30 pregnant women. The correlation between 
these test methods is shown in fig. 3. 
The use of detergent in the post-antigen washing 
procedure was found to be of prime importance in 
reducing non-specific adsorption of serum proteins 
onto the bound antibody. Repeated assays with the 
purified glycoprotein were extremely reproduceable 
without the presence of Triton X-100, but very 
inconsistent results were obtained from serum samples 
unless the detergent was incorporated into the buffer. 
The incubation times employed were not necessarily 
optimum. Longer periods, of up to 24 hr, produced 
a more sensitive assay but the reproduceability was 
poor, perhaps in part due to HRP instability. However 
the time periods used provided an assay of sufficient 
sensitivity to cover the expected range of PAM concen- 
191 
Volume 47, number 1 FEBS LETTERS October 1974 
15- 
. . 
E- . 
P. l . 
. 
. . 
lo- . 
..’ . . 
: l .* 
w l . 
d . 
2 . l 
P 
2 . l 
2 5- 
. 
. 
$ . 
w 
. 
. 
Fig. 3. Correlation between PAM concentration of 30 samples 
of pregnancy serum as measured by the enzyme-immunoassay 
and quantitative immunoelectrophoresis. 
trations [ 1 l] and allowed the assay to be completed 
in a single working day. 
By employing a ‘sandwich-type’ immunoassay with 
HRP as marker and the antibody bound to polystyrene 
tubes a simple, sensitive method has been developed 
for estimating PAM concentrations in serum. This 
should facilitate further studies into the role of the 
macromolecule. 
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